This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): cetirizine
Description: Zyrtec (Cetirizine) is an orally active and selective H1-receptor antagonist.
Deal Structure: In 1987, UCB and Pfizer signed a licensing agreement for Zyrtec (cetirizine) for the US territory. Both companies have been co-promoting Zyrtec in the US since 1996.
Partners: UCB SA
Additional information available to subscribers only: